Abbott Laboratories (ABT)
107.30
+2.03
(+1.93%)
USD |
NYSE |
Apr 19, 16:00
107.26
-0.04
(-0.04%)
After-Hours: 16:59
Abbott Laboratories SG&A Expense (Quarterly): 2.724B for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.724B |
September 30, 2023 | 2.723B |
June 30, 2023 | 2.74B |
March 31, 2023 | 2.762B |
December 31, 2022 | 2.973B |
September 30, 2022 | 2.731B |
June 30, 2022 | 2.757B |
March 31, 2022 | 2.787B |
December 31, 2021 | 3.048B |
September 30, 2021 | 2.767B |
June 30, 2021 | 2.726B |
March 31, 2021 | 2.783B |
December 31, 2020 | 2.57B |
September 30, 2020 | 2.302B |
June 30, 2020 | 2.276B |
March 31, 2020 | 2.548B |
December 31, 2019 | 2.413B |
September 30, 2019 | 2.44B |
June 30, 2019 | 2.434B |
March 31, 2019 | 2.478B |
December 31, 2018 | 2.359B |
September 30, 2018 | 2.377B |
June 30, 2018 | 2.466B |
March 31, 2018 | 2.542B |
December 31, 2017 | 2.477B |
Date | Value |
---|---|
September 30, 2017 | 2.115B |
June 30, 2017 | 2.15B |
March 31, 2017 | 2.44B |
December 31, 2016 | 1.673B |
September 30, 2016 | 1.628B |
June 30, 2016 | 1.737B |
March 31, 2016 | 1.698B |
December 31, 2015 | 1.655B |
September 30, 2015 | 1.666B |
June 30, 2015 | 1.727B |
March 31, 2015 | 1.737B |
December 31, 2014 | 1.666B |
September 30, 2014 | 1.595B |
June 30, 2014 | 1.649B |
March 31, 2014 | 1.62B |
December 31, 2013 | 1.541B |
September 30, 2013 | 1.612B |
June 30, 2013 | 1.714B |
March 31, 2013 | 1.786B |
December 31, 2012 | 1.158B |
September 30, 2012 | 1.920B |
June 30, 2012 | 1.814B |
March 31, 2012 | 1.842B |
December 31, 2011 | -2.486B |
September 30, 2011 | 4.239B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
2.276B
Minimum
Jun 2020
3.048B
Maximum
Dec 2021
2.658B
Average
2.726B
Median
Jun 2021
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.941B |
Boston Scientific Corp | 1.379B |
Edwards Lifesciences Corp | 478.80M |
Insulet Corp | 212.80M |
Intuitive Surgical Inc | 567.10M |